News You Can Use
Updates and news related to prostate cancer:
Focal Therapy in Grade Group 3 Prostate Cancer
Treatment of intermediate risk prostate cancer remains controversial.
PSMA PET Beats MRI in Prostate Cancer Staging Study
Findings support PSMA PET in the preoperative workflow of intermediate- and high-risk tumors
More Health Benefits from Plant-Based Diet
Men with prostate cancer could significantly reduce the chances of the disease worsening by eating more fruits, vegetables, nuts, and olive oil, according to new research by UC San Francisco.
Active Surveillance Yields Similar Outcomes to Prostate Cancer Treatment
"We hope this study encourages a national acceptance of active surveillance as an effective management strategy for prostate cancer,” says Daniel Lin, MD.
Metformin Fails to Stop Early Prostate Cancer Progression
Study suggests it may even be detrimental in some groups of patients on active surveillance.
Expert Discusses Advances, Unmet Needs Across Prostate Cancer Continuum
Highlights from the 2024 Prostate Cancer Academy
Pluvicto May Slow Progression Earlier in Advanced Prostate Cancer
Treatment with Pluvicto following ARPI resulted in favorable progression and response outcomes in PSMA-positive mCRPR.
SBRT and Hormone Therapy May Delay Advanced Prostate Cancer Progression
Stereotactic body radiotherapy and hormone treatment resulted in 40.1% 12-month progression-free survival in a recent study.
What’s New in Immunotherapy for Prostate Cancer?
Hope for the future of prostate cancer treatment: the possibility of immune memory
Low Testosterone Linked With Mortality Risk in Aging Men
Meta-analysis examined studies with mass spectroscopy measures, providing greater accuracy